Paulson Wealth Management Inc. - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLK and the CUSIP is 81369Y803. A total of 1,648 filers reported holding SELECT SECTOR SPDR TR in Q3 2023. The put-call ratio across all filers is 1.76 and the average weighting 0.7%.

Quarter-by-quarter ownership
Paulson Wealth Management Inc. ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$290,484
-5.7%
1,7720.0%0.10%
-2.9%
Q2 2023$308,080
+15.1%
1,7720.0%0.10%
-11.8%
Q1 2023$267,590
+21.4%
1,7720.0%0.12%
+10.2%
Q4 2022$220,508
+5.0%
1,7720.0%0.11%
-4.4%
Q3 2022$210,000
-6.7%
1,7720.0%0.11%
-5.0%
Q2 2022$225,000
-20.2%
1,7720.0%0.12%
-7.8%
Q1 2022$282,000
-8.4%
1,7720.0%0.13%
-6.5%
Q4 2021$308,000
+16.2%
1,7720.0%0.14%
+9.5%
Q3 2021$265,000
+1.1%
1,7720.0%0.13%
-0.8%
Q2 2021$262,000
+3.1%
1,7720.0%0.13%
+0.8%
Q1 2021$254,000
+10.4%
1,7720.0%0.13%
-6.0%
Q4 2020$230,000
+8.0%
1,772
-2.9%
0.13%
-2.9%
Q3 2020$213,000
-45.5%
1,824
-54.7%
0.14%
-50.0%
Q4 2019$391,000
+13.0%
4,028
-6.2%
0.28%
+5.7%
Q3 2019$346,000
-15.6%
4,294
-14.1%
0.26%
-14.7%
Q2 2019$410,000
-18.7%
5,001
-26.5%
0.31%
-19.9%
Q1 2019$504,000
-4.5%
6,807
-17.1%
0.38%
-12.4%
Q4 2018$528,000
-26.9%
8,212
-20.1%
0.44%
-32.7%
Q3 2018$722,0000.0%10,278
-1.2%
0.65%
-9.1%
Q2 2018$722,000
-6.2%
10,398
-11.7%
0.71%
-6.9%
Q1 2018$770,000
-34.4%
11,776
-35.8%
0.77%
-25.7%
Q4 2017$1,174,00018,3561.03%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2023
NameSharesValueWeighting ↓
Thinkbetter Group LLC 194,674$30,083,00030.65%
AGF Investments LLC 1,539,773$229,919,00022.69%
WestEnd Advisors, LLC 2,521,958$376,578,828,00011.33%
Advisors Preferred, LLC 537,338$81,444,00011.32%
Lunia Capital LP 3,000$448,0009.97%
Evolution Wealth Advisors, LLC 301,742$45,056,0009.66%
Biltmore Wealth Management, LLC 157,102$23,458,0009.39%
Conservest Capital Advisors, Inc. 546,203$81,559,0009.19%
Leicht Financial Planning & Wealth Management, Inc. 96,942$14,980,0009.00%
INNEALTA CAPITAL, LLC 105,798$15,798,0008.85%
View complete list of SELECT SECTOR SPDR TR shareholders